HAE
HEALTHCAREHaemonetics Corp
$52.67-2.95 (-5.30%)PRE
Live · NYSE · May 9, Close
AI Insight
What's Moving HAE Today?
No stock-specific AI insight has been generated for HAE yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$47.32$87.32
$52.67
Fundamentals
Market Cap$2.4B
P/E Ratio14.5
EPS$3.63
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.1%
Debt / Equity—
Trading
Volume1.3M
Avg Volume (10D)—
Shares Outstanding46.5M
HAE News
21 articles- Haemonetics (HAE) Q4 2026 Earnings TranscriptMotley Fool·May 8, 2026
- Haemonetics Corporation Q4 2026 Earnings Call SummaryMoby·May 8, 2026
- Haemonetics: Fiscal Q4 Earnings SnapshotWKYC·May 7, 2026
- Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to SayYahoo Finance·May 7, 2026
- Haemonetics (HAE) Q4 Earnings and Revenues Surpass EstimatesYahoo Finance·May 7, 2026
- Haemonetics (NYSE:HAE) Reports Upbeat Q1 CY2026Yahoo Finance·May 7, 2026
- Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations WebsiteYahoo Finance·May 7, 2026
- Envista (NVST) Surpasses Q1 Earnings and Revenue EstimatesYahoo Finance·May 6, 2026
- Haemonetics to Present at Bank of America 2026 Healthcare ConferenceYahoo Finance·May 5, 2026
- 3 Cash-Producing Stocks We Keep Off Our RadarYahoo Finance·May 3, 2026
- Will VASCADE MVP XL’s Expanded FDA Labeling Shift Haemonetics’ (HAE) Electrophysiology Growth NarrativeYahoo Finance·Apr 28, 2026
- New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure ProceduresYahoo Finance·Apr 24, 2026
- Riverwater Sustainable Value Strategy Awaits Haemonetics Corporation’s (HAE) Market ValidationYahoo Finance·Apr 21, 2026
- Mizuho Adjusts Haemonetics Corporation (HAE) Estimates in Sector-Wide ReviewYahoo Finance·Apr 17, 2026
- 1 Value Stock on Our Buy List and 2 Facing HeadwindsYahoo Finance·Apr 6, 2026
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026Yahoo Finance·Apr 1, 2026
- Is It Time To Reassess Haemonetics (HAE) After Prolonged Share Price WeaknessYahoo Finance·Apr 1, 2026
- GVS SpA (STU:4YQ) Q4 2025 Earnings Call Highlights: Strong Safety Division Growth Amidst ChallengesYahoo Finance·Mar 31, 2026
- Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure SystemYahoo Finance·Mar 30, 2026
- 3 Small-Cap Stocks That Fall ShortYahoo Finance·Mar 23, 2026
- What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past YearMotley Fool·Mar 20, 2026
All 21 articles loaded
Price Data
Open$55.93
Previous Close$55.62
Day High$56.74
Day Low$52.50
52 Week High$87.32
52 Week Low$47.32
52-Week Range
$47.32$87.32
$52.67
Fundamentals
Market Cap$2.4B
P/E Ratio14.5
EPS$3.63
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.1%
Debt / Equity—
Trading
Volume1.3M
Avg Volume (10D)—
Shares Outstanding46.5M
About Haemonetics Corp
Haemonetics Corporation, a healthcare company, offers medical products and solutions. The company is headquartered in Boston, Massachusetts.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—